Protagonist Therapeutics:
Proprietary peptide technology platform to develop oral targeted therapy-based drugs and injectables for rare diseases. PTG-300 injectable hepcidin mimetic Ph 2 trials ongoing in polycythemia vera and hereditary hemochromatosis; updated Phase 2 results in PV expected by YE 2020. PN-943 oral GI-restricted alpha-4-beta-7 antagonist Ph 2 in ulcerative colitis to begin early 2020; PTG-200, partnered w/ Janssen, oral GI-restricted IL-23R antagonist Ph 2 Crohn’s disease study ongoing.
Sector/Industry:
Healthcare/Biotechnology
Characteristics:
Based in...
US - Pacific
Clinical Stage
Phase l or ll
Disease Space
Anti-inflammatory, Gastrointestinal, Hematology, Rare Disease
Finance
Pre-Revenues
Industry
Biotechnology
Listing
Public, USA
Market Cap
500MM - 1B
Therapeutic Modalities
Platform Technology
Website:
Address:
521 Cottonwood Drive
Suite 100
Milpitas, CA 95035
United States
Suite 100
Milpitas, CA 95035
United States
Presentation:
Company Participants at Protagonist Therapeutics PTG-300 Opportunity Update Webinar
- Dinesh V Patel, PhD, President & CEO
More info:
My account:
Top 10 Holders of Protagonist Therapeutics, Inc.
| Institution | OS (%) | Position | Mkt Val ($MM) | Source | Filing Date |
|---|---|---|---|---|---|
| Fidelity Management & Research Co. LLC | 19.59 | 5,147,005 | 113.23 | 13F | 6/30/20 |
| RTW Investments LP | 12.87 | 3,383,208 | 74.43 | 13F | 6/30/20 |
| Farallon Capital Management LLC | 9.51 | 2,500,000 | 55.00 | 13F | 6/30/20 |
| Johnson & Johnson Innovation JJDC, Inc. | 9.32 | 2,449,183 | 53.88 | 13F | 6/30/20 |
| BVF, Inc. | 9.01 | 2,367,288 | 52.08 | 13F | 6/30/20 |
| Adage Capital Partners GP LLC | 8.37 | 2,200,000 | 48.40 | 13F | 6/30/20 |
| Adage Capital Management LP | 8.37 | 2,200,000 | 48.40 | Stakes | 5/13/20 |
| Baker Bros. Advisors LP | 7.27 | 1,911,446 | 42.05 | 13F | 6/30/20 |
| Vanguard Group, Inc. (Subfiler) | 5.18 | 1,361,782 | 29.96 | 13F | 6/30/20 |
| The Vanguard Group, Inc. | 4.97 | 1,309,862 | 28.82 | Funds | 8/31/20 |
Ownership data is sourced through FactSet.
Stock Market Data
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2020 QuoteMedia.
Data delayed 15 minutes unless otherwise indicated (view
delay times for all
exchanges). RT=Real-Time, RTB=Real-Time
BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time
NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of
Day, PD=Previous Day. Market Data powered by
QuoteMedia.
Terms of Use.